Navigation Links
OmniComm Systems, Inc. Raises $5.1 Million in Convertible Debt Financing
Date:12/17/2008

t were originally issued in February 2008.

"This transaction strengthens the Company's balance sheet by immediately improving our working capital position and giving us more operating flexibility," said Ronald Linares, CFO of OmniComm. "In addition, by effectively eliminating our secured debt obligations we believe we have positioned ourselves for improved future flexibility for financing our growth."

In accordance with SEC regulations, the Company has filed a report on Form 8K containing more details of the transaction.

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid- size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Chicago, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term
'/>"/>

SOURCE OmniComm Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
2. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
3. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
4. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
5. FDA Grants Clearance to Langford IC Systems, Inc.
6. Four Rivers Software Systems, Inc. Announces the Promotion of Samantha Rouse to Senior Vice President of Product and Services
7. CAS Medical Systems, Inc. Ranked Among Connecticuts Fastest Growing Technology Companies
8. StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc.
9. Acclamation Systems, Inc. Renews Partnership with Coalition America to Offer Streamlined Repricing and Adjudication Solution
10. RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US
11. AdCare Health Systems, Inc. Announces 2007 Third Quarter Earnings Release and Conference Call Schedule

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... CHICAGO,Nov.24/PRNewswire/--Theholidayseasoncanbe...tformanypeople,especiallythoserecoveringfromaneati...eflectiononpastfailuresandanxietyaboutanuncertainf...neatingdisordercanbechallengingandsometimesawkward...ocentexposuretoovereatingwiththefamily and duringt...
(Date:11/24/2009)... DALLAS,Nov.24/PRNewswire-USNewswire/--TheBaylorCh...eofthelargestcancerclinicaltrialscooperativegroups...ionalCancerInstitute,SouthwestOncologyGroupconduct...toimprovethequalityoflifeforcancersurvivors. ,,...itional,importantclinicaltrialstocancerpatientsinN...
(Date:11/24/2009)... NEWYORK,Nov.24/PRNewswire/-- Asyear-endapproache...savetaxesthisyearandnext.Tohelpyoutakeadvantageoft...,SeniorTaxAnalystatThomsonReuters,highlightsthefol...s: ,, Healthflexiblespendingaccounts(HealthFS...tunitytosavetaxesbyplacingfundsintheiremployer,she...
(Date:11/24/2009)... LAKESUCCESS,N.Y.,Nov.24/PRNewswire-USNewswire/--I...aninternationalqualitymanagementstandardfocusedonf...isfactionandcontinuallyimprovingbusinessperformanc...tificationServicesmeansIPRO,sQualityManagementSyst...operationsatitsofficesinLakeSuccessandAlbany,NewYo...
(Date:11/24/2009)... Physician recruiting firm Locum...ian staffing, is pleased to announce its agreement...provide physicians for locum tenens assignments. ...ovember 24, 2009 -- Physician recruiting firm L...hysician staffing, is pleased to announce its agre...
Breaking Medicine News(10 mins):Health News:When Holiday Meals Aren't a Gift 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2
...n in the US suffer from erectile dysfunction (ED),...seases, including heart diseases. // The number of...r the condition was introduced in 1998. The data a...,126 men aged over 20 years responded to this surv...
...ton conducted a survey in 5 European countries on ...nd domestic life // to find out whether women enj...ave a traditional life style, the work was funded ...s found that women who worked hard to achieve grea...
...n the maternity care is expected, with a London- b...e to one service, for pregnant women who pay ?4,00...een Charlotte's and Chelsea Hospital. // The p...and. However, it continues to be the gold standard...
...s for long to detect the cause of blindness-induci...macular// degeneration (AMD) and retinitis pigment...re genetic, but the problem was that AMD and RP be...n-Madison researchers worked with fruit flies and ...
... cycling across the Indian state of Rajasthan in a...he women and children living in the state.// She w...een 16 November and 26 November 2006. Jayne Watson...se over 2,700 pounds as a part of an initiative by...
...nion' is being developed by scientists, which can ... beings. Scientists belonging to the European Cogn...ion of robots will be able to think for themselves...they want the robot to look like and do, they pred...
Other Medicine News:Health News:London Hospital Provides Specialized Care For Pregnant Women 2
(Date:11/24/2009)...alif.,Nov.24/PRNewswire/--SatelliteHealthcare,oneo...isservicesandamajorsponsorofnephrologyresearch,tod...chefEliasNasrallahinhisefforttosupporttheSanJoseho...hbuiltasuccessfulcareerasachefforthepast20years.Bu...henhewasdiagnosedwithEndStageRenalDisease(ESRD).Th...
(Date:11/24/2009).../PRNewswire/--AFOXThanksgivingDaytelevisionspecial...emindsviewersthattheholidaysareatimetobegratefulfo...thosewhofightthatbattleeachdayassurvivors,caregive...storicreturntotheiceofcancersurvivorsScottHamilton...ohnandDavidFosterwhowillperform"HopeisAlwaysHere,"...
(Date:11/23/2009)....23/PRNewswire-USNewswire/--FebeDurango-Rueda,52,a...ticipatinginaschemetodefraudtheExport-ImportBankof...uncedAssistantAttorneyGeneraloftheCriminalDivision...tacosoftheEx-ImBank,OfficeoftheInspectorGeneral. ,...tsinU.S.DistrictCourtinWashingtontoaone-countcrimi...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Cepheid Reports 2009 Second Quarter Results 53277 1Cepheid Reports 2009 Second Quarter Results 53277 2Cepheid Reports 2009 Second Quarter Results 53277 3Cepheid Reports 2009 Second Quarter Results 53277 4Cepheid Reports 2009 Second Quarter Results 53277 5Cepheid Reports 2009 Second Quarter Results 53277 6Cepheid Reports 2009 Second Quarter Results 53277 7Cepheid Reports 2009 Second Quarter Results 53277 8Cepheid Reports 2009 Second Quarter Results 53277 9Cepheid Reports 2009 Second Quarter Results 53277 10Cepheid Reports 2009 Second Quarter Results 53277 11Cepheid Reports 2009 Second Quarter Results 53277 12Cepheid Reports 2009 Second Quarter Results 53277 13Cepheid Reports 2009 Second Quarter Results 53277 14Cepheid Reports 2009 Second Quarter Results 53277 15Cepheid Reports 2009 Second Quarter Results 53277 16Cepheid Reports 2009 Second Quarter Results 53277 17Cepheid Reports 2009 Second Quarter Results 53277 18Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 1Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 2Flu Shot May Be Less Effective in Those With Lupus 53274 1Flu Shot May Be Less Effective in Those With Lupus 53274 2
...II Study Results Presented At ASCO -- , CHICAGO &n...h,pegylated interferon alfa-2b in stage III melano...se-free survival (RFS),according to the results o...ients with stage III melanoma. Results of the Phas...the Research and,Treatment of Cancer (EORTC) and s...
... Largest Ever Phase III Clinical Trial in,Lung Can...wire-FirstCall/ --,GlaxoSmithKline today announced...ical trial of its investigational MAGE-A3,Antigen-...3,positive patients with stage IB or II Non-Small ...d at the 2007 American Society of,Clinical Oncolog...
Other Medicine Technology:Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 2Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 3Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 4Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 5Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 6
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: